Maravai Lifesciences Holdings Inc.

Maravai Lifesciences Holdings Inc. is a leading life sciences company focused on providing critical products and services to enable the development of drug therapies, diagnostics, and novel vaccines. The company operates in two segments: Nucleic Acid Production and Biologics Safety Testing. Maravai's nucleic acid production segment offers a range of modified nucleic acids, including mRNA, used in gene therapy, mRNA-based vaccines, and diagnostic applications. The biologics safety testing segment provides services to ensure the safety and purity of biopharmaceuticals, including antibody-based therapies and vaccines. By providing vital components and testing services, Maravai Lifesciences plays a crucial role in advancing scientific research and improving human health through innovative life science solutions and supports pharmaceutical and biotechnology companies in their quest to develop cutting-edge treatments.